Reduction of Kcnt1 is therapeutic in mouse models of SCN1A and SCN8A epilepsy.

Hill, Sophie F; Jafar-Nejad, Paymaan; Rigo, Frank; Meisler, Miriam H

Reduction of Kcnt1 is therapeutic in mouse models of SCN1A and SCN8A epilepsy.

Hill, Sophie F; Jafar-Nejad, Paymaan; Rigo, Frank; Meisler, Miriam H.

Afiliação

Hill SF; Neuroscience Graduate Program, University of Michigan, Ann Arbor, MI, United States.
Jafar-Nejad P; Department of Human Genetics, University of Michigan, Ann Arbor, MI, United States.
Rigo F; Ionis Pharmaceuticals, Carlsbad, CA, United States.
Meisler MH; Ionis Pharmaceuticals, Carlsbad, CA, United States.

Front Neurosci ; 17: 1282201, 2023.

Article em En | MEDLINE | ID: mdl-37901435

Palavras-chave

ASO; Kcnt1; Scn1a; Scn8a; epilepsy; potassium channel; sodium channel

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Neurosci Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google